Opko Health OPK Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Diagnostics | $16.04M-12.5% | $11.04M-58.8% | $14.84M+19.5% | $18.72M-16.1% | $18.33M+7.7% | |
| Pharmaceutical | $29.71M+22.3% | $52.99M-8.4% | $35.05M+26.5% | $30.68M+4.6% | $24.29M-3.0% | |
| Operating Income by Business | ||||||
| Diagnostics | -$12.95M+45.8% | —— | $81.63M+39.4% | -$18.16M+31.7% | -$23.92M+30.5% | |
| Pharmaceutical | -$29.68M+14.6% | -$10.68M-409% | -$24.19M+24.9% | -$28.71M-15.7% | -$34.77M-25.6% | |
| Total Assets by Business | ||||||
| Diagnostics | $343.37M-28.9% | $349.1M-29.3% | $376.99M-27.2% | $476.22M-21.7% | $482.67M-21.9% | |
| Pharmaceutical | $1.3B— | $1.33B-2.4% | $1.32B+4.0% | $1.34B+7.6% | —— | |
| Selling General And Administrative Expense by Business | ||||||
| Diagnostics | $26.15M-31.1% | $26.47M-39.8% | $31.5M-55.6% | $33.37M-25.0% | $37.96M-17.1% | |
| Pharmaceutical | $14.21M+11.8% | $14.9M+8.4% | $13.06M-13.9% | $13.2M-6.2% | $12.71M-15.5% | |
| Research And Development Expense by Business | ||||||
| Diagnostics | $312K-42.0% | $326K-38.5% | $289K-41.4% | $484K+25.4% | $538K-19.1% | |
| Pharmaceutical | $28.75M-4.9% | $32.25M+8.0% | $29.64M+5.0% | $29.78M+25.7% | $30.24M+42.3% | |
| D&A by Business | ||||||
| Diagnostics | $3.93M-31.1% | $4.09M-31.6% | $4.7M-23.2% | $4.89M-21.8% | $5.7M-27.6% | |
| Pharmaceutical | $18.26M+2.7% | $18.28M+1.2% | $18.04M0.0% | $18.14M+1.3% | $17.79M-0.9% | |
| Goodwill by Business | ||||||
| Diagnostics | $163.44M0.0% | $163.44M-25.6% | $163.44M-25.6% | $163.44M-24.9% | $163.44M-24.9% | |
| Pharmaceutical | $318.83M— | $320.85M+3.7% | $320.59M+1.4% | $320.74M+2.7% | —— | |
| Cost of Goods Sold by Business | ||||||
| Diagnostics | $56.14M-33.6% | $60.05M-21.3% | $80.4M-26.1% | $82.38M-23.1% | $84.52M-23.1% | |
| Pharmaceutical | $22.3M-2.3% | $24.38M+7.5% | $21.37M-13.3% | $25.02M+6.7% | $22.81M+4.9% | |
| Amortization Of Intangible Assets by Business | ||||||
| Diagnostics | $2.53M-32.5% | $2.53M-36.2% | $2.99M-24.0% | $3.03M-24.5% | $3.75M-24.9% | |
| Pharmaceutical | $16.43M+2.0% | $16.52M+0.9% | $16.54M+0.3% | $16.42M0.0% | $16.11M-2.0% | |
| Goodwill Foreign Currency Translation Gain Loss by Business | ||||||
| Diagnostics | $0— | $0— | $0— | $0— | $0— | |
| Pharmaceutical | -$1.76M— | $22K+100% | —— | —— | —— | |
| Goodwill Impaired Accumulated Impairment Loss by Business | ||||||
| Diagnostics | $17.98M0.0% | $17.98M0.0% | $17.98M0.0% | $17.98M0.0% | $17.98M0.0% | |
| Pharmaceutical | $11.7M— | $11.7M0.0% | $11.7M0.0% | $11.7M0.0% | —— | |
| Revenue by Product | ||||||
| Intellectual Property And Other | $14M+13.8% | —— | $18.7M+41.7% | $15M+22.0% | $12.3M— | |
| Rayaldee | $12.81M-2.3% | $16.87M-15.0% | $14.88M-6.2% | $14.53M-21.1% | $13.11M-13.5% | |
| Transfer Of Intellectual Property And Other | $13.97M+13.9% | $33.72M-21.8% | $18.75M+41.8% | $14.96M+21.6% | $12.27M+40.2% | |
| Cost of Goods Sold by Product | ||||||
| Product | $22.3M-2.3% | $24.38M+7.5% | $21.37M-13.3% | $25.02M+6.7% | $22.81M+4.9% | |
| Service | $56.14M-33.6% | $60.05M-21.3% | $80.4M-26.1% | $82.38M-23.1% | $84.52M-23.1% | |
| Revenue by Geography | ||||||
| CL | $14.87M+2.3% | $17.48M+9.4% | $14.36M-13.4% | $16M-9.1% | $14.53M-2.4% | |
| ES | $8.05M+25.0% | $7.22M+6.1% | $6.34M+0.6% | $6.72M+14.5% | $6.44M+13.8% | |
| IE | $9.68M+76.6% | $22.1M+24.0% | $12.08M+4.9% | $11.74M+19.3% | $5.48M-40.6% | |
| IL | $0-100% | $171K-82.5% | $140K-28.6% | $139K-68.5% | $73K-54.4% | |
| MX | $6.94M+11.4% | $6.26M+19.3% | $6.74M+19.7% | $6.3M+6.6% | $6.23M-12.1% | |
| Other Countries | $1.15M+16.3% | $1.17M+25.1% | $1.09M+44.7% | $1.02M+26.6% | $992K+57.5% | |
| US | $83.5M-28.1% | $94.05M-30.8% | $110.92M-16.4% | $114.88M-18.9% | $116.21M-14.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Opko Health break its business down?
- Opko Health (OPK) reports gross profit by business across 2 parts — Diagnostics and Pharmaceutical. Each is extracted from the segment footnotes and tracked over time.
- Where does Opko Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Opko Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
